Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 3
×
Mesothelioma
×
Nivolumab
×
Clear all
Filters
3
NCT06097728
2026-03-04
eVOLVE-Meso
AstraZeneca
Phase 3
Recruiting
825 enrolled
NCT04334759
2026-01-22
DREAM3R
PrECOG, LLC.
Phase 3
Completed
214 enrolled
NCT03063450
2025-04-10
CONFIRM
University of Southampton
Phase 3
Completed
332 enrolled
NCT02899299
2024-05-21
CheckMate743
Bristol-Myers Squibb
Phase 3
Completed
605 enrolled
17 charts
2 FDA